Bioventus Inc.
BVS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001665988
No open-market purchases or sales by Bioventus Inc. insiders were filed in the last 90 days; 156 institutions reported holding it in 13F filings for Q2 2026, worth $509.4M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Bioventus Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 94
- −4 vs. Q2 2022
- Shares held
- 35.1M
- +1.09M (+3.2%) vs. Q2 2022
- Total value
- $245.9M
- +$13.9M (+6.0%) vs. Q2 2022
- New holders
- 11
- 36 more added
- Sold out
- 15
- 28 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 156 | $509.4M |
| Q1 2026 | 157 | $466.4M |
| Q4 2025 | 148 | $373.3M |
| Q3 2025 | 135 | $328.9M |
| Q2 2025 | 134 | $320.3M |
| Q1 2025 | 144 | $427.0M |
| Q4 2024 | 151 | $477.8M |
| Q3 2024 | 138 | $537.1M |
| Q2 2024 | 103 | $222.2M |
| Q1 2024 | 84 | $178.0M |
| Q4 2023 | 80 | $175.4M |
| Q3 2023 | 67 | $108.9M |
| Q2 2023 | 66 | $92.6M |
| Q1 2023 | 71 | $33.4M |
| Q4 2022 | 85 | $81.9M |
| Q3 2022 | 94 | $245.9M |
| Q2 2022 | 98 | $232.0M |
| Q1 2022 | 105 | $447.0M |
| Q4 2021 | 98 | $451.6M |
| Q3 2021 | 69 | $351.8M |
| Q2 2021 | 53 | $364.5M |
| Q1 2021 | 45 | $334.2M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Bioventus Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Principal Financial Group Inc | 0 | $0 | 0.00% | −10,995−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,373−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −10,132−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −7,007−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −2,303−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −232−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −155−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |